Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
4.53M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
750K
-
Shares change
-
+568K
-
Total reported value, excl. options
-
$1.53M
-
Value change
-
+$1.15M
-
Number of buys
-
10
-
Price
-
$2.11
Significant Holders of PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) as of Q4 2024
11 filings reported holding PBM - PSYENCE BIOMEDICAL LTD. - Common Shares, without par value as of Q4 2024.
PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 750K shares
of 4.53M outstanding shares and own 16.56% of the company stock.
Largest 10 shareholders include Hudson Bay Capital Management LP (380K shares), Harraden Circle Investments, LLC (182K shares), Essential Planning, LLC. (73.3K shares), AdvisorShares Investments LLC (26.9K shares), HRT FINANCIAL LP (26.1K shares), UBS Group AG (12.7K shares), Virtu Financial LLC (12.7K shares), CITADEL ADVISORS LLC (11.5K shares), Scientech Research LLC (11.2K shares), and Connective Capital Management, LLC (11.1K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.